Legal
Important Safety Information
Product specific safety information for medications offered through protocolhrt.com.
Effective Date: October 12, 2026 Last Updated: October 12, 2026 Version: 1.0
IF YOU THINK YOU ARE HAVING A MEDICAL EMERGENCY, CALL 911 OR GO TO THE NEAREST EMERGENCY ROOM NOW. IF YOU ARE HAVING THOUGHTS OF SUICIDE OR ARE IN CRISIS, CALL OR TEXT 988.
1. About This Page
1.1 Who wrote this page. This page summarizes important safety information for the prescription medications that licensed providers affiliated with LocumTele, an independent medical group (the “Medical Group”), may prescribe to patients who use protocolhrt.com. Its clinical content was approved by the Medical Group. It does not replace a conversation with your provider, the label on your medication, or the information the pharmacy gives you. Not every medication here will be right for you, and a prescription is issued only if your provider decides it is appropriate. ProtocolHRT is not a medical practice or pharmacy.
1.2 Tell your provider everything. Give your provider a complete and accurate medical history, including all prescription and over-the-counter medicines, vitamins and supplements, allergies, pregnancy or plans to become pregnant, and breastfeeding. Never share your medication or needles with anyone.
1.3 About compounded medications. Several medications on this page are compounded. A compounded medication is prepared by a state-licensed pharmacy for one patient based on a prescription. Compounded medications are not FDA-approved. The FDA does not review compounded medications for safety, effectiveness or quality before they are dispensed. They are not generic versions of, the same as, or substitutes for any FDA-approved drug. Their strength, purity and stability can vary, and they may have risks that are not yet known. Where FDA-approved options exist, your provider can review them with you.
1.4 Report side effects. If you have a side effect, contact your provider through the patient portal or by calling ProtocolHRT support at 1-888-219-2204, which routes clinical questions to the Medical Group’s Providers. You may also report side effects to the FDA at www.fda.gov/medwatch or by calling MedWatch at 1-800-FDA-1088.
2. Compounded Tirzepatide Injection
2.1 Status. Compounded tirzepatide is prepared by a state-licensed 503A compounding pharmacy for you individually when your provider decides it is appropriate and documents why it is right for you. It is not FDA-approved, has no FDA-approved labeling, and is not a generic version of any brand-name medicine. It is used, when your provider prescribes it, together with a reduced-calorie diet and more physical activity. FDA-approved medicines are available for weight management; ask your provider about them.
2.2 Warning: risk of thyroid tumors. FDA-approved medicines that contain tirzepatide carry a Boxed Warning, the FDA’s most serious warning. In studies in rats, tirzepatide caused thyroid C-cell tumors. It is not known whether it causes these tumors, including a thyroid cancer called medullary thyroid carcinoma (MTC), in people. Your provider treats this risk as applying to compounded tirzepatide. Tell your provider if you get a lump or swelling in your neck, hoarseness, trouble swallowing or shortness of breath.
2.3 Who should not use it. Do not use compounded tirzepatide if you or a family member has ever had MTC; if you have Multiple Endocrine Neoplasia syndrome type 2 (MEN 2); if you have had a serious allergic reaction to tirzepatide or any ingredient in the preparation; or if you are pregnant.
2.4 Tell your provider first if you. Have or have had problems with your pancreas, gallbladder or kidneys; have severe stomach or bowel problems, including slow stomach emptying; have diabetic eye disease; take insulin or a sulfonylurea; take any other GLP-1 or tirzepatide product; use birth control pills; have a history of depression or mood changes; are planning surgery or a procedure with anesthesia or sedation; or are pregnant, planning to become pregnant or breastfeeding.
2.5 Warnings. Tirzepatide can cause inflammation of the pancreas (pancreatitis), gallbladder problems, kidney injury from dehydration caused by vomiting or diarrhea, low blood sugar when used with insulin or a sulfonylurea, serious allergic reactions, worsening diabetic eye disease, and severe stomach problems. It slows stomach emptying, which can raise the risk of inhaling stomach contents during anesthesia or deep sedation; tell every clinician who plans a procedure that you use it. It may make birth control pills work less well, so your provider may tell you to use a non-oral method or add a barrier method for four (4) weeks after you start and after each dose increase. Tell your provider right away about any new or worsening depression, suicidal thoughts or unusual changes in mood or behavior.
2.6 Common side effects. Nausea, diarrhea, vomiting, constipation, stomach pain, indigestion, decreased appetite, injection-site reactions, tiredness, belching, heartburn and hair loss.
2.7 Medicines that may interact. Insulin and sulfonylureas (risk of low blood sugar); birth control pills and other medicines taken by mouth, because tirzepatide slows stomach emptying; other GLP-1 or tirzepatide products (do not combine).
2.8 Dosing errors. Compounded tirzepatide may come in a vial with a concentration different from other products you have used. Measure every dose exactly as the pharmacy’s label and your provider’s instructions say. Dosing errors with compounded GLP-1 medicines have caused serious side effects and hospital visits.
2.9 Get emergency help right away for. Severe stomach pain that does not go away, with or without vomiting, that may spread to your back; swelling of your face, lips, tongue or throat, or trouble breathing or swallowing; shakiness, sweating, confusion or a fast heartbeat that does not improve; or signs of severe dehydration, such as very little urine, dizziness or fainting.
2.10 More information. This is not all the safety information. Talk with your provider and the pharmacy about the risks. Report side effects to your provider and to the FDA at www.fda.gov/medwatch or 1-800-FDA-1088.
3. Testosterone Injection (TRT Core)
3.1 Status. Testosterone cypionate injection prescribed through protocolhrt.com is compounded, except for patients in California, who receive the FDA-approved commercial product. Testosterone cypionate injection is an FDA-approved prescription medicine used to replace testosterone in men whose bodies make too little of it because of certain medical conditions (primary hypogonadism or hypogonadotropic hypogonadism). Current labels state that its safety and effectiveness in men with low testosterone due to aging alone have not been established. If your testosterone injection is compounded, it is not FDA-approved, and Section 1.3 applies.
3.2 Controlled substance. Testosterone is a Schedule III controlled substance. Before your first prescription, your provider will see you in a live video visit, and in person where your state requires it, and will order lab tests. It is for your use only. Sharing or selling it is illegal.
3.3 Who should not use it. Do not use testosterone if you have breast cancer or known or suspected prostate cancer; if you are a woman who is pregnant or may become pregnant; if you have serious heart, liver or kidney disease; or if you are allergic to testosterone or any ingredient, including cottonseed oil.
3.4 Blood pressure and the class labeling update. In 2025, the FDA required updates to the labels of all testosterone products. The updates added the results of a large study of heart safety in men with low testosterone, which did not find a higher overall rate of heart attack, stroke or heart-related death, and added a warning that testosterone can raise blood pressure, which can increase the risk of heart attack, stroke and other major heart problems. Your provider will check your blood pressure before and during treatment. In 2026, the FDA asked manufacturers to make further label changes; your provider follows the current label.
3.5 Other warnings. Testosterone can raise your red blood cell count (hematocrit), which can increase the risk of blood clots; has been linked to blood clots in the legs (deep vein thrombosis) and lungs (pulmonary embolism); can worsen urinary symptoms from an enlarged prostate; may increase the risk of prostate cancer being found; can worsen sleep apnea; can cause swelling from fluid buildup, especially if you have heart, kidney or liver disease; can lower sperm production and may cause infertility; and can cause breast enlargement.
3.6 Abuse and dependence. Testosterone can be abused. Taking more than prescribed, or using it with other anabolic steroids, can cause serious problems, including heart attack, heart failure, stroke, liver problems, depression and aggressive or hostile behavior. Stopping high doses suddenly can cause withdrawal symptoms such as depression, tiredness, irritability, low sex drive and trouble sleeping. Take only the dose your provider prescribes.
3.7 Common side effects. Injection-site pain or swelling, acne, increased red blood cell count, changes in lab results such as PSA, and changes in mood.
3.8 Medicines that may interact. Blood thinners such as warfarin; insulin and other diabetes medicines (your blood sugar may change); corticosteroids (more fluid buildup).
3.9 Monitoring. Your provider will order blood tests before and during treatment, including testosterone level, hematocrit and, where appropriate, PSA, and will check your blood pressure. Keep your lab and follow-up appointments; your prescription may not be renewed without them.
3.10 Get emergency help right away for. Chest pain; shortness of breath; pain, swelling or warmth in one leg; sudden weakness or numbness, trouble speaking or face drooping; an erection that lasts more than four (4) hours; or signs of a serious allergic reaction.
3.11 More information. This is not all the safety information. Read the Prescribing Information and Medication Guide the pharmacy gives you, and talk with your provider. Report side effects to your provider and to the FDA at www.fda.gov/medwatch or 1-800-FDA-1088.
4. Compounded Oral Testosterone (Chewable Tablet)
4.1 Status. This oral testosterone is a compounded chewable tablet prepared by a state-licensed compounding pharmacy for you individually. It is not FDA-approved, and the FDA has not reviewed it for safety, effectiveness or quality. It is not the same as, or a generic version of, any FDA-approved oral testosterone product. How much testosterone your body absorbs from it can vary, so your provider will monitor your blood levels.
4.2 Controlled substance. Testosterone is a Schedule III controlled substance. Before your first prescription, your provider will see you in a live video visit, and in person where your state requires it, and will order lab tests. It is for your use only. Sharing or selling it is illegal.
4.3 Who should not use it. Do not use it if you have breast cancer or known or suspected prostate cancer; if you are a woman who is pregnant or may become pregnant; if you have serious heart, liver or kidney disease; or if you are allergic to testosterone or any ingredient in the tablet.
4.4 Blood pressure and the class labeling update. FDA-approved testosterone products taken by mouth carry a Boxed Warning, the FDA’s most serious warning, that they can raise blood pressure, which can increase the risk of heart attack, stroke and heart-related death. Your provider treats this risk as applying to compounded oral testosterone. In 2025, the FDA required updates to the labels of all testosterone products, adding the results of a large heart safety study and a warning about increased blood pressure. Your provider will check your blood pressure before and during treatment.
4.5 Other warnings. The warnings in Section 3.5 also apply: higher red blood cell count, blood clots, worsening urinary symptoms from an enlarged prostate, prostate cancer risk, worsening sleep apnea, fluid buildup, lower sperm production and infertility, and breast enlargement. Tell your provider if you have liver disease.
4.6 Abuse and dependence. Testosterone can be abused. Taking more than prescribed can cause serious problems, including heart attack, stroke, liver problems, depression and aggressive behavior, and stopping high doses suddenly can cause withdrawal symptoms. Take only the dose your provider prescribes.
4.7 Common side effects. Acne, increased red blood cell count, changes in lab results such as PSA, headache, mouth or gum irritation, and changes in mood.
4.8 Medicines that may interact. Blood thinners such as warfarin; insulin and other diabetes medicines; corticosteroids.
4.9 How to take it. Take it exactly as your provider prescribes and as the pharmacy’s label directs. Keep it in its child-resistant container, locked away from children and others.
4.10 Get emergency help right away for. Chest pain; shortness of breath; pain, swelling or warmth in one leg; sudden weakness or numbness, trouble speaking or face drooping; a severe headache or other signs of very high blood pressure; or signs of a serious allergic reaction.
4.11 More information. This is not all the safety information. Talk with your provider and the pharmacy about the risks. Report side effects to your provider and to the FDA at www.fda.gov/medwatch or 1-800-FDA-1088.
5. Tadalafil Tablets
5.1 Status. Tadalafil prescribed through protocolhrt.com is compounded, except for patients in California, who receive the FDA-approved commercial product. Tadalafil tablets are FDA-approved to treat erectile dysfunction (ED) and the symptoms of an enlarged prostate (BPH). Tadalafil 20 mg tablets are also sold under other names to treat pulmonary arterial hypertension (PAH). If your tadalafil is compounded, it is not FDA-approved, and Section 1.3 applies.
5.2 Who should not use it. Do not take tadalafil if you take any nitrate medicine (such as nitroglycerin or isosorbide), use recreational “poppers” (amyl or butyl nitrite), or take riociguat (Adempas). The combination can cause a sudden, dangerous drop in blood pressure. Do not take it if you are allergic to tadalafil, or with another ED medicine or with tadalafil prescribed for PAH.
5.3 Warnings. Sexual activity can strain the heart; talk to your provider if you have heart problems. Tadalafil can lower blood pressure, especially with alpha-blockers, other blood pressure medicines or a lot of alcohol. Rarely, it can cause sudden vision loss in one or both eyes or sudden hearing loss. If you need emergency nitroglycerin, tell the medical team when you last took tadalafil; at least forty-eight (48) hours should pass before a nitrate is considered.
5.4 Common side effects. Headache, indigestion, back pain, muscle aches, flushing, and stuffy or runny nose.
5.5 Medicines that may interact. Nitrates and riociguat (do not combine); alpha-blockers and other blood pressure medicines; HIV protease inhibitors and certain antifungal medicines and antibiotics, such as ketoconazole, itraconazole and clarithromycin; other ED medicines; alcohol in large amounts.
5.6 Get emergency help right away for. An erection lasting more than four (4) hours; sudden vision loss in one or both eyes; sudden hearing loss or ringing in the ears with dizziness; chest pain during or after sex; or fainting.
5.7 More information. This is not all the safety information. Read the Patient Information the pharmacy gives you, and talk with your provider. Report side effects to your provider and to the FDA at www.fda.gov/medwatch or 1-800-FDA-1088.
6. Sildenafil Tablets
6.1 Status. Sildenafil prescribed through protocolhrt.com is compounded, except for patients in California, who receive the FDA-approved commercial product. Sildenafil tablets in 25, 50 and 100 mg strengths are FDA-approved to treat erectile dysfunction in men. Sildenafil is not approved for use in women. Sildenafil 20 mg tablets are approved to treat pulmonary arterial hypertension (PAH). If your sildenafil is compounded, it is not FDA-approved, and Section 1.3 applies.
6.2 Who should not use it. Do not take sildenafil if you take any nitrate medicine (such as nitroglycerin or isosorbide), use recreational “poppers” (amyl or butyl nitrite), or take riociguat (Adempas). The combination can cause a sudden, dangerous drop in blood pressure. Do not take it if you are allergic to sildenafil, or with another ED medicine or with sildenafil prescribed for PAH.
6.3 Warnings. Sexual activity can strain the heart; talk to your provider if you have heart problems. Sildenafil can lower blood pressure, especially with alpha-blockers or other blood pressure medicines. Rarely, it can cause sudden vision loss in one or both eyes or sudden hearing loss. Do not take it more than once a day.
6.4 Common side effects. Headache, flushing, upset stomach, changes in vision (such as a blue tint or blurred vision), stuffy nose, back pain, muscle aches, nausea, dizziness and rash.
6.5 Medicines that may interact. Nitrates and riociguat (do not combine); alpha-blockers and other blood pressure medicines; HIV protease inhibitors and certain antifungal medicines and antibiotics, such as ketoconazole, itraconazole and erythromycin; other ED medicines.
6.6 Get emergency help right away for. An erection lasting more than four (4) hours; sudden vision loss in one or both eyes; sudden hearing loss or ringing in the ears with dizziness; chest pain during or after sex; or fainting.
6.7 More information. This is not all the safety information. Read the Patient Information the pharmacy gives you, and talk with your provider. Report side effects to your provider and to the FDA at www.fda.gov/medwatch or 1-800-FDA-1088.
7. Compounded Oxytocin
7.1 Status. Compounded oxytocin nasal spray is prepared by a state-licensed 503A compounding pharmacy for you individually. It is not FDA-approved. The only FDA-approved oxytocin is an injection given in a hospital during labor and after delivery. Oxytocin is not FDA-approved for sexual wellness or any use offered through protocolhrt.com. Your provider will discuss the possible benefits, risks and alternatives, including FDA-approved options, before prescribing it. Not available in California.
7.2 Who should not use it. Do not use oxytocin if you are pregnant or may be pregnant, or if you are allergic to oxytocin or any ingredient in the preparation.
7.3 Warnings. Oxytocin can cause the body to hold on to too much water, which can lower the sodium level in your blood, especially if you drink large amounts of fluid. It can also raise or lower blood pressure and affect heart rhythm. Tell your provider if you have high blood pressure, heart disease, seizures or kidney problems.
7.4 Common side effects. Headache, nausea, nasal irritation (for nasal forms), and changes in mood.
7.5 Medicines that may interact. Medicines that raise blood pressure or narrow blood vessels, including some decongestants and migraine medicines; other sexual wellness medicines; medicines that affect sodium or fluid balance, such as diuretics.
7.6 Get emergency help right away for. Severe headache, confusion, vomiting, seizures, unusual swelling or weight gain, a fast or irregular heartbeat, or signs of a serious allergic reaction.
7.7 More information. This is not all the safety information. Talk with your provider and the pharmacy about the risks. Report side effects to your provider and to the FDA at www.fda.gov/medwatch or 1-800-FDA-1088.
8. Compounded Sermorelin Injection
8.1 Status. Compounded sermorelin is prepared by a state-licensed compounding pharmacy for you individually. It is not FDA-approved. No sermorelin product is currently FDA-approved and marketed in the United States. Sermorelin is not human growth hormone (HGH). It is not FDA-approved to treat aging, improve athletic performance or change body composition.
8.2 Athletes. Sermorelin is prohibited at all times under the World Anti-Doping Code. If you are subject to drug testing in sport, do not use it.
8.3 Who should not use it. Do not use sermorelin if you are allergic to sermorelin or any ingredient in the preparation, or if you are pregnant or breastfeeding. Tell your provider if you have or have had cancer, diabetes, or thyroid or pituitary disease.
8.4 Warnings. Sermorelin may affect blood sugar and thyroid function. Your provider may check lab tests, such as IGF-1, before and during treatment.
8.5 Common side effects. Pain, redness or swelling where you inject; flushing; headache; dizziness; sleepiness; and hives.
8.6 Medicines that may interact. Thyroid medicines; corticosteroids; insulin and other diabetes medicines; other growth hormone or peptide products (do not combine unless your provider tells you to).
8.7 Get emergency help right away for. Swelling of the face, lips, tongue or throat; trouble breathing; chest tightness; fainting; or fever or chills after an injection.
8.8 More information. This is not all the safety information. Talk with your provider and the pharmacy about the risks. Report side effects to your provider and to the FDA at www.fda.gov/medwatch or 1-800-FDA-1088.
9. Compounded NAD+ Injection and NAD+ Nasal Spray
9.1 Status. Compounded NAD+ injection and NAD+ nasal spray are prepared by a state-licensed 503A compounding pharmacy for you individually. No NAD+ product is FDA-approved in any form. NAD+ is not FDA-approved to treat, cure or prevent any disease or to slow aging. The FDA allows NAD+ to be compounded only under a temporary policy while it evaluates the ingredient, and that policy could change. NAD+ nasal spray is not available in California.
9.2 Ingredient quality. In 2024 the FDA warned that some compounders had used NAD+ ingredients not suitable for medical use, and patients had reactions such as severe chills, shaking and vomiting. The pharmacy that fills your prescription must use an ingredient from an FDA-registered manufacturer.
9.3 Who should not use it. Do not use NAD+ if you are allergic to NAD+ or any ingredient in the preparation, or if you are pregnant or breastfeeding. Tell your provider if you have or have had cancer, and about all medicines and supplements you take.
9.4 Common side effects of the injection. Pain, redness or swelling where you inject, flushing, nausea, stomach cramping, headache, tiredness and a feeling of chest tightness.
9.5 Common side effects of the nasal spray. Nasal irritation or congestion, headache, flushing and nausea.
9.6 Medicines that may interact. Tell your provider about all medicines and supplements you take, including niacin or other vitamin B3 products.
9.7 Get emergency help right away for. Trouble breathing; chest pain or tightness that does not go away; fainting; swelling of the face, lips, tongue or throat; or fever, severe chills or shaking after a dose.
9.8 More information. This is not all the safety information. Talk with your provider and the pharmacy about the risks. Report side effects to your provider and to the FDA at www.fda.gov/medwatch or 1-800-FDA-1088.
10. Compounded Glutathione Injection
10.1 Status. Compounded glutathione injection is prepared by a state-licensed compounding pharmacy for you individually. No glutathione product is FDA-approved in any form. Glutathione is not FDA-approved to lighten skin or to treat, cure or prevent any disease. The FDA allows it to be compounded only under a temporary policy while it evaluates the ingredient, and that policy could change. Not available in California.
10.2 Recent safety alerts. Since August 2026, the FDA and the Centers for Disease Control and Prevention have reported a multistate outbreak of serious illness in people who received injectable glutathione made with an ingredient labeled for dietary supplement use and contaminated with bacterial toxins (endotoxin). People reported fever, chills, low blood pressure and sepsis-like symptoms, and some were hospitalized. Several compounding pharmacies have recalled glutathione injections. The pharmacy that fills your prescription must use an ingredient from an FDA-registered manufacturer that is suitable for injection. If you have glutathione from any source, check for recall notices and do not use a product that has been recalled.
10.3 Who should not use it. Do not use glutathione if you are allergic to glutathione or any ingredient in the preparation, or if you are pregnant or breastfeeding. Tell your provider if you have asthma or have ever had a reaction to sulfites.
10.4 Warnings. Glutathione can cause allergic reactions and, in people with asthma, breathing problems. Do not use any vial that looks cloudy, has particles, is past its beyond-use date or arrived damaged.
10.5 Common side effects. Pain, redness or swelling where you inject, flushing, nausea, rash and stomach upset.
10.6 Medicines that may interact. Tell your provider about all medicines and supplements you take, including treatments for cancer.
10.7 Get emergency help right away for. Fever, chills, shaking, a fast heartbeat, dizziness or fainting after a dose; trouble breathing or wheezing; chest tightness; or swelling of the face, lips, tongue or throat.
10.8 More information. This is not all the safety information. Talk with your provider and the pharmacy about the risks. Report side effects to your provider and to the FDA at www.fda.gov/medwatch or 1-800-FDA-1088.
11. Using and Storing Injectable Medications
- Use each medication exactly as your provider prescribes and as the pharmacy’s label directs, including the storage temperature and beyond-use date.
- Use a new sterile needle and syringe every time, clean the vial top and your skin with alcohol, and never share needles.
- Dispose of needles in a sharps container, and keep all medications out of reach of children and pets.
- If a medication arrives warm, damaged or leaking, or looks different from what you expect, do not use it. Call the pharmacy at the number on your label.
NOT FOR EMERGENCIES. IN A MEDICAL EMERGENCY, CALL 911. IN CRISIS, CALL OR TEXT 988.